BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 6158494)

  • 1. Endothelial fenestrae in proliferative diabetic retinopathy.
    Wallow IH; Geldner PS
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1176-83. PubMed ID: 6158494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subretinal neovascularization complicating laser photocoagulation of diabetic maculopathy.
    Lewen RM
    Ophthalmic Surg; 1988 Oct; 19(10):734-7. PubMed ID: 2461540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Panphotocoagulation in simple and proliferative diabetic retinopathy].
    Mirkiewicz-Sieradzka B; Romanowska B; Zygulska-Machowa H
    Klin Oczna; 1988 Sep; 90(9):317-9. PubMed ID: 2469824
    [No Abstract]   [Full Text] [Related]  

  • 4. Chorioretinal and choriovitreal neovascularization after photocoagulation for proliferative diabetic retinopathy. A clinicopathologic correlation.
    Wallow I; Johns K; Barry P; Chandra S; Bindley C
    Ophthalmology; 1985 Apr; 92(4):523-32. PubMed ID: 2582332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time span of regression or disappearance of optic disk neovascularisation in proliferative diabetic retinopathy after panretinal argon laser photocoagulation and results over a two-year follow-up.
    Theodossiadis GP; Ismiridis KJ
    Fortschr Ophthalmol; 1987; 84(5):465-7. PubMed ID: 2448214
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of clustered fenestrae of chorioretinal vessels in pathologic conditions.
    Kohno T
    Osaka City Med J; 1993 Nov; 39(2):151-66. PubMed ID: 8183535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural characteristics of new vessels in proliferative diabetic retinopathy.
    Williams JM; de Juan E; Machemer R
    Am J Ophthalmol; 1988 May; 105(5):491-9. PubMed ID: 2453120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of panretinal photocoagulation in preproliferative and proliferative ischemic diabetic retinopathy: apropos of 235 eyes followed for 6 months to 8 years].
    Annonier MP; Soubrane G; Coscas G
    Bull Soc Ophtalmol Fr; 1986 Nov; 86(11):1363-6. PubMed ID: 2438059
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diabetic maculopathy and proliferative retinopathy: their relation and the results of photocoagulation].
    Nikolić Lj; Radović N
    Srp Arh Celok Lek; 1985 Aug; 113(8):655-63. PubMed ID: 2418513
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser treatment in diabetic retinopathy.
    O'Donoghue HN
    Trans Ophthalmol Soc U K (1962); 1982; 102 (Pt 4)():468-70. PubMed ID: 6194597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current options in management: proliferative diabetic eye disease.
    Barrie T
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 2)():125-32. PubMed ID: 6198786
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetic neovascularization: permeability and ultrastructure.
    Miller H; Miller B; Zonis S; Nir I
    Invest Ophthalmol Vis Sci; 1984 Nov; 25(11):1338-42. PubMed ID: 6208163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review and a model.
    Wolbarsht ML; Landers MB
    Ophthalmic Surg; 1980 Apr; 11(4):235-45. PubMed ID: 6155650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of successful photocoagulation in proliferative diabetic retinopathy.
    Freyler H; Klemen U; Egerer I
    Mod Probl Ophthalmol; 1979; 20():396-400. PubMed ID: 95031
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy.
    Gendron RL; Good WV; Adams LC; Paradis H
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3000-7. PubMed ID: 11687548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetic retinopathy preproliferating and proliferating. Clinical forms and treatment].
    Guyot-Argenton C
    Journ Annu Diabetol Hotel Dieu; 1988; ():151-61. PubMed ID: 2459437
    [No Abstract]   [Full Text] [Related]  

  • 18. [Panretinal photocoagulation and proliferative diabetic retinopathy. Results of a long-term prospective study (2d report)].
    Chaine G; Zerah I; Coscas G
    Bull Soc Ophtalmol Fr; 1986 Nov; 86(11):1369-72. PubMed ID: 2438060
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of diabetic retinopathy lesions of the posterior pole and retinal periphery in 200 diabetics].
    Devlamynck S; Bondu G
    Bull Soc Ophtalmol Fr; 1982 Dec; 82(12):1593-6. PubMed ID: 6191882
    [No Abstract]   [Full Text] [Related]  

  • 20. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
    Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.